{
    "1": {
        "question": "What did the researchers discover about the correlation between 5-HT2A receptor Gq-efficacy and psychedelic potential?",
        "options": {
            "A": "Gq-efficacy is irrelevant to psychedelic potential.",
            "B": "A high Gq-efficacy is necessary to induce psychedelic-like effects.",
            "C": "Only \u03b2-arrestin2 activity predicts psychedelic potential.",
            "D": "Both Gq and \u03b2-arrestin2 activities are required for psychedelic effects.",
            "E": "Neither Gq nor \u03b2-arrestin2 activities correlate with psychedelic potential.",
            "F": "I don't know."
        }
    },
    "2": {
        "question": "How does \u03b2-arrestin2-bias affect 5-HT2A receptor downregulation?",
        "options": {
            "A": "It prevents receptor downregulation entirely.",
            "B": "It induces receptor downregulation and tachyphylaxis.",
            "C": "It has no effect on receptor downregulation.",
            "D": "It only affects receptor downregulation when combined with Gq-signaling.",
            "E": "It enhances Gq-signaling effects without causing downregulation.",
            "F": "I don't know."
        }
    },
    "3": {
        "question": "What role does W3366.48 play in 5-HT2A receptor biased agonism?",
        "options": {
            "A": "It stabilizes the receptor in its inactive state.",
            "B": "It acts as a toggle switch influencing biased agonism.",
            "C": "It enhances Gq-signaling exclusively.",
            "D": "It's irrelevant to biased agonism.",
            "E": "It causes receptor degradation.",
            "F": "I don't know."
        }
    },
    "4": {
        "question": "What structural modification was shown to increase 5-HT2A R selectivity?",
        "options": {
            "A": "Removal of N-benzyl substitution.",
            "B": "Addition of 2-bromo in the N-benzyl ring.",
            "C": "Addition of a hydroxyl group to the C7\u2019 position.",
            "D": "Introduction of a naphthyl ring.",
            "E": "None of the modifications increased selectivity.",
            "F": "I don't know."
        }
    },
    "5": {
        "question": "What does a lack of head-twitch response (HTR) indicate in mice with \u03b2-arrestin-biased 5-HT2A R agonists?",
        "options": {
            "A": "The compounds have strong psychedelic effects.",
            "B": "The compounds are non-psychedelic.",
            "C": "The compounds fail to reach the central nervous system.",
            "D": "The compounds enhance Gq-signaling but not \u03b2-arrestin2 activity.",
            "E": "The compounds induce neurotoxicity.",
            "F": "I don't know."
        }
    },
    "6": {
        "question": "What impact does the addition of a larger N-substituted group have on 5-HT2A R activity?",
        "options": {
            "A": "It increases both Gq and \u03b2-arrestin2 activity.",
            "B": "It decreases both activities, lowering receptor efficacy.",
            "C": "It reduces Gq activity while preserving \u03b2-arrestin2 activity.",
            "D": "It enhances receptor degradation.",
            "E": "It increases overall selectivity for 5-HT2B receptors.",
            "F": "I don't know."
        }
    },
    "7": {
        "question": "In structure-activity relationship studies, what feature was found to influence 5-HT2A receptor selectivity?",
        "options": {
            "A": "Introducing a methyl group on the C5' position.",
            "B": "The electrostatic properties of the N-benzyl ring.",
            "C": "The stereochemistry of the N-benzyl amine.",
            "D": "The length of the carbon chain in alkyl substituents.",
            "E": "The overall molecular weight of the compound.",
            "F": "I don't know."
        }
    },
    "8": {
        "question": "Which psychedelic compound demonstrated superagonism in Figure 1?",
        "options": {
            "A": "LSD.",
            "B": "25I-NBOMe.",
            "C": "DMT.",
            "D": "DOI.",
            "E": "2C-I.",
            "F": "I don't know."
        }
    },
    "9": {
        "question": "What was observed about 5-HT2A receptor activity at longer time points?",
        "options": {
            "A": "No changes in receptor preferences were noted.",
            "B": "There was an increase in receptor bias towards \u03b2-arrestin2.",
            "C": "Effects on Gq and \u03b2-arrestin were similar and mirrored 5-HT.",
            "D": "Receptor activity ceased entirely.",
            "E": "Only Gq activity was increased substantially.",
            "F": "I don't know."
        }
    },
    "10": {
        "question": "What was the significance of the observed Gq-efficacy threshold?",
        "options": {
            "A": "Suggested \u03b2-arrestin is unnecessary for psychedelic effects.",
            "B": "Explained why non-psychedelic 5-HT2A agonists fail to induce certain effects.",
            "C": "Indicated Gq activity was dominant over \u03b2-arrestin2.",
            "D": "Revealed complete independence of Gq signaling in psychedelic effects.",
            "E": "It was deemed irrelevant for drug development.",
            "F": "I don't know."
        }
    },
    "11": {
        "question": "Which assay technique was used to measure 5-HT2A G protein and \u03b2-arrestin activity?",
        "options": {
            "A": "NMR spectroscopy.",
            "B": "Mass spectrometry.",
            "C": "Bioluminescence resonance energy transfer (BRET).",
            "D": "Electrophysiology.",
            "E": "Optical imaging.",
            "F": "I don't know."
        }
    },
    "12": {
        "question": "What structural feature was identified to reduce steric clash and increase ligand selectivity and potency?",
        "options": {
            "A": "Bigger substituents at the para position.",
            "B": "Removing all substituents from N-benzyl.",
            "C": "Adding a methoxy group to the ortho position.",
            "D": "Biphenyl structures.",
            "E": "2- and 3-position substitutions with bulky groups on the N-benzyl ring.",
            "F": "I don't know."
        }
    },
    "13": {
        "question": "Figure 4 demonstrates that 25N derivatives induce HTR under what condition?",
        "options": {
            "A": "High Gq-efficacy is present.",
            "B": "\u03b2-Arrestin2 bias is enhanced.",
            "C": "Both Gq and \u03b2-arrestin2 activities are low.",
            "D": "No specific efficacy condition; all derivatives induce HTR.",
            "E": "Low receptor occupancy only.",
            "F": "I don't know."
        }
    },
    "14": {
        "question": "Which compound was specifically manipulated to achieve a \u03b2-arrestin-biased profile?",
        "options": {
            "A": "25N-NBOH.",
            "B": "25CN-NBOH.",
            "C": "25N-N1-Nap.",
            "D": "2C-I.",
            "E": "Psilocin.",
            "F": "I don't know."
        }
    },
    "15": {
        "question": "What finding supported the model of 5-HT2A receptor bias being dependent in part on interactions with W3366.48?",
        "options": {
            "A": "W3366.48 mutations prevented any 5-HT2A R activities.",
            "B": "Ligands induced a distinct W3366.48 rotamer conformation associated with arrestin-bias.",
            "C": "There was no alteration in W3366.48 conformational state.",
            "D": "W3366.48 acted only to enhance Gq-dissociation.",
            "E": "The activation of W3366.48 was correlated with hallucinogenic effects.",
            "F": "I don't know."
        }
    },
    "16": {
        "question": "Which agonist showed no preference for either 5-HT2A R-Gq or 5-HT2A R-\u03b2-arrestin2?",
        "options": {
            "A": "25N-NBOH.",
            "B": "Psilocin.",
            "C": "25N-NBI.",
            "D": "DMT.",
            "E": "DOI.",
            "F": "I don't know."
        }
    },
    "17": {
        "question": "What was the observed effect of \u03b2-arrestin-biased 5-HT2A receptor agonists on PCP-induced hyperactivity?",
        "options": {
            "A": "These agonists completely failed to block PCP effects.",
            "B": "They enhanced PCP-induced hyperactivity significantly.",
            "C": "They blocked PCP-induced hyperactivity.",
            "D": "They had no effect on PCP-induced effects.",
            "E": "They accelerated PCP-induced effects.",
            "F": "I don't know."
        }
    },
    "18": {
        "question": "Which substitute was used in Figure 2 to enhance 5-HT2A receptor selectivity in the 2-halogen series?",
        "options": {
            "A": "2-fluoro.",
            "B": "2-chloro.",
            "C": "2-bromo.",
            "D": "2-iodo.",
            "E": "2-iodoketo.",
            "F": "I don't know."
        }
    },
    "19": {
        "question": "How was ligand efficacy measured in terms of predicting the psychedelic potential of compounds?",
        "options": {
            "A": "By their ability to inhibit a calcium flux only.",
            "B": "Through their Gq-efficacy and overall agonistic profile.",
            "C": "Based solely on \u03b2-arrestin2 recruitment.",
            "D": "By their non-receptor specific binding.",
            "E": "Through their dissociation constant alone.",
            "F": "I don't know."
        }
    },
    "20": {
        "question": "What did molecular dynamics simulations reveal about the W3666.48 toggle switch in regards to biased 5-HT2A R ligands?",
        "options": {
            "A": "It does not change conformation with bias.",
            "B": "It transitions similarly with inactive systems.",
            "C": "It prefers a specific rotamer conformation with biased ligands.",
            "D": "It exhibits more variance with unbiased ligands.",
            "E": "It is directly correlated with receptor degradation.",
            "F": "I don't know."
        }
    }
}